3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clinical Assessment of Urinary Tract Damage during Sustained-Release Estrogen Supplementation in Mice

      research-article

      Read this article at

      ScienceOpenPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Estrogen supplementation is a key component of numerous mouse research models but can adversely affect the urinary system. The goal of this study was to develop a clinical scoring system and identify biomarkers of occult urinary tract lesions prior to the development of systemic illness in mice. Ovariectomized or sham-surgery SCID mice were implanted subcutaneously with a placebo pellet or one containing sustained-release estradiol (0.18 mg 60-d release 17β-estradiol). Mice were assessed twice weekly for 4 to 6 wk by using a clinical scoring system that included body condition, general activity, posture, hair coat, hydration, abdominal distension, urine staining of coat and skin, and ability to urinate. Samples were collected weekly for urinalysis, BUN, creatinine, and serum estradiol levels. Terminal samples were analyzed for histopathologic lesions. Compared with placebo controls, estradiol-supplemented mice had higher serum estradiol levels at weeks 2 and 3; significant differences in total clinical scores by the 3-wk time point; and in body condition, general activity, posture, hair coat, and urine staining scores by the 6-wk terminal time point. Urinary tract lesions included hydronephrosis, pyelonephritis, cystitis, and urolithiasis. All mice with urolithiasis had crystalluria, and 5 of the 6 mice with pyelonephritis or hydroureter had dilute urine (that is, specific gravity less than 1.030). However, these findings were not specific to mice with lesions. A total clinical score of 3.5 (maximum, 24) identified estradiol-supplemented mice with 83% specificity and 50% sensitivity, but no single clinical parameter, biomarker, or the total clinical score accurately predicted occult urinary tract lesions. Considering the lesions we observed, prudence is warranted when using pelleted sustained-release estradiol in mice, and important parameters to monitor for animal health include urine staining, body condition score, urine sediment, and urine specific gravity.

          Related collections

          Author and article information

          Journal
          Comp Med
          Comp. Med
          cm
          Comparative Medicine
          American Association for Laboratory Animal Science
          1532-0820
          February 2017
          February 2017
          : 67
          : 1
          : 11-21
          Affiliations
          [1 ]Unit for Laboratory Animal Medicine (ULAM)
          [2 ]In Vivo Animal Core (IVAC), and
          [3 ]School of Dentistry, University of Michigan, Ann Arbor, Michigan, and
          [4 ]College of Veterinary Medicine, Michigan State University, Lansing, Michigan
          Author notes
          [* ]Corresponding author. Email: jvillano@ 123456umich.edu
          [†]

          Current affiliation: Center for Comparative Medicine, Baylor College of Medicine,Houston Texas

          Article
          PMC5310620 PMC5310620 5310620 2017000011
          5310620
          28222835
          60892a1a-1fb5-4541-8af9-ca2e22cb781b
          © American Association for Laboratory Animal Science
          History
          : 09 May 2016
          : 12 June 2016
          : 12 July 2016
          Page count
          Pages: 11
          Categories
          Mouse Models

          Comments

          Comment on this article